Abstract:RNA interference (RNAi) inhibits gene expression by specifically degrading target mRNAs. Since the discovery of double-stranded small interference RNA (siRNA) in gene silencing(1), RNAi has become a powerful research tool in gene function studies. Compared to genetic deletion, RNAi-mediated gene silencing possesses many advantages, such as the ease with which it is carried out and its suitability to most cell lines. Multiple studies have demonstrated the applications of RNAi technology in cancer research. In particular, the development of the DNA vectorbased technology to produce small hairpin RNA (shRNA) driven by the U6 or H1 promoter has made long term and inducible gene silencing possible(2,3). Its use in combination with genetically engineered viral vectors, such as lentivirus, facilitates high efficiencies of shRNA delivery and/or integration into genomic DNA for stable shRNA expression.We describe a detailed procedure using the DNA vector-based RNAi technology to determine gene function, including construction of lentiviral vectors expressing shRNA, lentivirus production and cell infection, and functional studies using a mouse xenograft model.Various strategies have been reported in generating shRNA constructs. The protocol described here employing PCR amplification and a 3-fragment ligation can be used to directly and efficiently generate shRNA-containing lentiviral constructs without leaving any extra nucleotide adjacent to a shRNA coding sequence. Since the shRNA-expression cassettes created by this strategy can be cut out by restriction enzymes, they can be easily moved to other vectors with different fluorescent or antibiotic markers. Most commercial transfection reagents can be used in lentivirus production. However, in this report, we provide an economic method using calcium phosphate precipitation that can achieve over 90% transfection efficiency in 293T cells. Compared to constitutive shRNA expression vectors, an inducible shRNA system is particularly suitable to knocking down a gene essential to cell proliferation. We demonstrate the gene silencing of Yin Yang 1 (YY1), a potential oncogene in breast cancer(4,5), by a Tet-On inducible shRNA system and its effects on tumor formation. Research using lentivirus requires review and approval of a biosafety protocol by the Biosafety Committee of a researcher's institution. Research using animal models requires review and approval of an animal protocol by the Animal Care and Use Committee (ACUC) of a researcher's institution.

The enhancement of RNAi against HIV in vitro and in vivo using H-2K(k) protein as a sorting method.

Efficient Inhibition of Human Cytomegalovirus DNA Polymerase Expression by Small Hairpin RNA in Vitro

Simultaneously Inhibition of Hiv and Hbv Replication Through A Dual Small Interfering Rna Expression System

Screening of Highly Effective Sirna Sequence Targeting to HIV-1 Vif and the Lentiviral-mediated Antiviral Research in Vitro

Short Communication: Efficiently Inhibiting HIV-1 Replication by a Prototype Foamy Virus Vector Expressing Novel H1 Promoter-Driven Short Hairpin RNAs

Lentiviral Vector Design for Multiple shRNA Expression and Durable HIV-1 Inhibition

Lentiviral Delivery of RNAi Effectors Against HIV-1

Inhibition of Hepatitis B Virus Gene Expression by Single and Dual Small Interfering RNA Treatment

Genome Scale Screening Identification of SaCas9/gRNAs for Targeting HIV-1 Provirus and Suppression of HIV-1 Infection

RNAi-inducing lentiviral vectors for anti-HIV-1 gene therapy

Specific Inhibition Of Hiv-1 Replication By Short Hairpin Rnas Targeting Human Cyclin T1 Without Inducing Apoptosis

Construction and Identification of a Lentiviral Vector for RNA Interference of APE1 Gene

Therapeutic Effect of RANTES–KDEL on Inhibition of HIV-1 in CD34+ Human Hematopoietic Stem Cells (Hhsc)

The effect of cassette order on gene expression knockdown by triple tRNA‐shRNA constructs designed for anti‐HIV gene therapy (749.6)

Anti-HIV-1 HSPC-based gene therapy with safety kill switch to defend against and attack HIV-1 infection

DNA Vector-Based RNA Interference to Study Gene Function in Cancer.

Long-term Stable Expression of Shrna Recombinant Lentiviral Vectors in the Hematopoietic System of Mice

Inhibition of HBV Replication and Gene Expression in Vitro and in Vivo with a Single AAV Vector Delivering Two Shrna Molecules.

T Cell-Specific Sirna Delivery Suppresses HIV-1 Infection in Humanized Mice

Hepatitis B Virus Inhibition in Mice by Lentiviral Vector Mediated Short Hairpin RNA.

Differential impact of transplantation on peripheral and tissue-associated viral reservoirs: Implications for HIV gene therapy.